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In her commentary, Tyl (2009) responded 
to our criticism (Myers et al. 2009) of her 
bisphenol A (BPA) research (Tyl et al. 2008), 
and she defended the reliance on Good 
Laboratory Practices (GLP) in animal stud-
ies concerning risks posed by chemicals. Her 
commentary, however, provides additional 
evidence that her research on BPA is flawed 
and that GLP can be unreliable.
The key evidence can be found in her 
treatment of the effect of BPA on pros-
tate weight (Tyl et al. 2008). This effect is 
important because Tyl’s data on adult pros-
tate in mice has been used by the chemi-
cal industry—which has funded all of Tyl’s 
research on BPA—and the Food and Drug 
Administration (FDA) to conclude that BPA 
has no effect at low doses. Indeed, Tyl argued 
that the weight of the evidence supports her 
findings that BPA is safe (all industry-funded 
studies report no low-dose effects of BPA). 
In contrast, > 200 studies in experimental 
animals, all funded by government agencies, 
have reported significant effects of BPA at 
low doses that are relevant to human and 
ecologic exposures (vom Saal et al. 2007).
We (Myers et al. 2009) concluded that 
prostate weights reported by Tyl et al. (2008) 
were abnormally high in control males, sug-
gesting either that the dissections were done 
improperly, that control animals were exposed 
to a contaminating estrogen, or that their 
prostates were diseased. This would render the 
results invalid and therefore inappropriate to 
use in assessing BPA safety. It would also pro-
vide insights as to why, despite many other 
studies showing adverse effects of exposure to 
BPA at low doses (vom Saal et al. 2007), Tyl 
et al. (2008) detected none.
To counter this criticism, Tyl (2009) 
presented a table (her Table 2) of mouse 
prostate weights from other laboratories. 
The data she presented in fact show that no 
other laboratory meas  uring prostate weight 
in mice has reported mean weights as high as 
those reported by Tyl et al. (2008), except in 
old male mice with diseased prostates. Tyl’s 
table cites data from research published by 
Heindel et al. (1995) previously conducted 
at her own institution, Research Triangle 
Institute, although she did not acknowledge 
this. The mean prostate weight reported by 
Heindel et al. (1995) for 16- to 17-week-old 
CD-1 male mice was 48 mg, which is similar 
to most other findings, but contrasts sharply 
with Tyl’s mean prostate weights of 74 mg for 
the F1 males in her BPA study (these males 
were identified in Table 1 of Tyl’s commen-
tary as being examined at 18 weeks of age). 
Table 2 of Tyl (2009) also includes data 
from a publication by Morrissey et al. (1988) 
showing a mean prostate weight of 58 mg 
in 23-week-old CD-1 mice. However, this 
study involved comparing data from two 
laboratories, and Tyl omitted from her table 
the data from the second laboratory that 
reported a mean prostate weight of 35 mg 
in 23-week-old CD-1 males. Morrissey et al. 
(1988) observed that the laboratory reporting 
the mean of 58 mg also had a higher standard 
deviation and lower statistical sensitivity than 
the laboratory reporting the 35 mg mean 
prostate weight. In studies in which pros-
tate weight is high, such as that of Tyl et al. 
(2008), the findings are suspect in that the 
abnormally high prostate weight data show a 
poor relationship to other male reproductive 
organs (Morrissey et al. 1988). This strongly 
suggests that non  prostatic tissue has been 
included when prostate weights are abnor-
mally high in the absence of disease. 
Tyl’s discussion of prostate weight effects 
also suggests that studies identified as GLP 
may not adhere to the strict record-keeping 
goals to which GLP aspires, undermining 
one of the arguments used for the value of 
GLP over research funding by the National 
Institutes of Health, which rarely follows the 
costly GLP guidelines. In the original pub-
lication, Tyl et al. (2008) reported that F1 
retained males were necropsied at approxi-
mately 14 weeks of age. In Table 1 of her 
commentary (Tyl 2009), Tyl stated that 
these males were 18 weeks of age at necropsy. 
However, in testimony before the FDA 
Science Board BPA Subcommittee hearing 
on 16 September 2008 (FDALive.com 2008), 
Tyl stated that these males were 24 weeks of 
age at necropsy as an explanation for their 
high prostate weights. Tyl assured the FDA 
panel that since “the difference in age influ-
ences growth rate and growth of organs, the 
comparison [of 12- and 24-week-old males] is 
specious, it is comparing apples and oranges.” 
In fact, Tyl’s data in Table 1 of her commen-
tary (Tyl 2009) show no relationship between 
age and body weight. The inconsistencies in 
Tyl’s FDA testimony, which could have had 
a significant impact on a regulatory decision 
concerning BPA, and the data concerning 
the age at tissue collection, prostate weights, 
and body weights presented in Table 1 of her 
commentary are disturbing, and indicate that 
a thorough review of original data in Tyl et al. 
(2008) by scientific experts is warranted. 
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I am responding to the comments by vom 
Saal and Myers on my commentary (Tyl 
2009), which was in response to their com-
mentary (Myers et al. 2009). Our dietary 
BPA mouse study was performed under 
Organisation for Economic Co-operation and 
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Development (OECD) Test Guideline 416 
(OECD 2001) and Good Laboratory 
Practices (GLPs) (OECD 1998), with in-
house quality control, and formal RTI qual-
ity assurance, and expert Developmental & 
Reproductive Toxicology (DART) panel 
oversight. We submitted all of our sum-
mary data online with our published mouse 
study (Tyl et al. 2008). I also discussed our 
BPA data, especially prostate weights (ven-
tral and dorsolateral lobes separately) and 
ages of animals at scheduled necropsy, two 
areas of concern to vom Saal and Myers, 
in my commentary (Tyl 2009). We found 
no BPA effects on mouse prostate weights 
at any dietary dose, from 3 µg/kg/day to 
600 mg/kg/day, whereas vom Saal and col-
leagues reported increased prostate weights 
at 2 and 20 µg/kg/day BPA, administered on 
gestational days 11–17 (Nagel et al. 1997). 
Vom Saal and Myers suggested that prostate 
weights were very large in our control mice 
(Tyl et al 2008), in his view, likely due to 
prostatitis and/or poor dissection techniques 
resulting in extraneous tissue left on the pros-
tates. We provided histo  pathologic confirma-
tion of low (normal) rates of prostatitis, no 
increased incidences or severities from BPA, 
and no evidence of extraneous tissue from 
examination of the prostate paraffin block 
faces and histology slides. For animal ages at 
termination, we initially presented approxi-
mate ages of our animals at demise because 
we were not aware of their concerns at that 
time. In a letter to the editor of Toxicological 
Sciences, where the multi  generational BPA 
rat and mouse studies (Tyl et al. 2002, 2008) 
were published, I (Tyl 2009) explained in 
great detail the ages of our F0, F1, and F2 ani-
mals at scheduled necropsy; the ages of the 
F1 animals varied at most by 3 weeks in all 
groups, based on when the F0 animals mated 
during the 2-week mating period, the need 
to have all F1 offspring exposed for at least 
8 weeks during the pre  breeding period, and 
the need for all F1s to be available for pairing 
in all groups at the same time. FDA auditors 
recently spent 11 days at RTI (30 March to 
9 April 2009) inspecting our BPA rat (Tyl 
et al. 2002) and mouse (Tyl et al. 2008) 
multi  generational reproductive toxicity study 
data and records, with no study findings.
It is clear that vom Saal and Myers appar-
ently still do not understand or appreciate the 
discipline, power, importance, and useful-
ness of GLPs on study design, performance, 
documentation, and interpretation (which is 
why GLP-compliant studies are preferentially 
used in formal hazard identification and risk 
assessment).
The effects of dose levels, route, timing 
(life stages), and duration of BPA exposures 
on reported early and late effects, and whether 
there is a linkage between the low-dose early 
end points from short-term, small, basic 
exploratory studies and the outcomes from 
long-term guideline studies, need to be evalu-
ated. Long-term, robust oral studies (Ashby 
et al. 1999; Cagen et al. 1999) and guideline-
compliant oral multi  generational studies (Ema 
et al. 2001; Tyl et al. 2002, 2008), regardless 
of sponsorship, have not confirmed the low-
dose effects reported in the basic studies, nor 
any long-term consequences anticipated from 
these reported early effects. Determination 
of whether there is hazard or risk of BPA to 
humans and wildlife from low, environmen-
tally relevant doses by relevant exposure routes 
is based on available appropriate data. To 
date, governmental and other organizational 
hazard, risk, and weight-of-evidence assess-
ments have concluded, based on the data, 
that there is no evidence of any adverse effects 
from oral BPA at low doses.
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